Human Xtensions

Human Xtensions Forward P/E

The Forward P/E Ratio of Human Xtensions (HUMX-M.TA) as of Nov 5, 2026 is -0.25. In the previous year, Forward P/E Ratio was -0.16 — a change of 59.48% (lower).

Forward P/E

-0.25

YoY

59.48%

Last updated:

Forward P/E Ratio of Human Xtensions is 2024 -0.25 . Forward P/E Ratio of Human Xtensions was 2023 -0.16 . It decreases by 59.48% lower compared to the previous year.

The Human Xtensions Forward P/E history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Forward P/E
Date
Forward P/E
Jan 1, 2018
-0.20 ILS
Jan 1, 2019
-0.12 ILS
Jan 1, 2020
-0.20 ILS
Jan 1, 2021
-0.11 ILS
Jan 1, 2022
-0.13 ILS
Jan 1, 2023
-0.16 ILS
Jan 1, 2024
-0.25 ILS
The Human Xtensions Forward P/E history
YEARForward P/EYoY
-0.25+59.48%
-0.16+21.72%
-0.13+20.25%
-0.11-46.77%
-0.20+72.21%
-0.12-41.86%
-0.20—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Human Xtensions Stock analysis

What does Human Xtensions do? Human Xtensions Ltd. develops and sells medical devices for minimally invasive surgery, including HandX, Fenestrated Gasper, Monopolar Hook, and Needle Holder. The company focuses on digital handheld devices that extend the human hand, providing surgeons with ergonomic positioning during procedures. Its products are marketed globally to healthcare providers and surgical teams seeking advanced tools for laparoscopic operations. The firm operates through its subsidiary Human Xtensions Inc. to serve international markets. The company's revenue comes from the sale of its product portfolio, with HandX being an electromechanical laparoscopic device designed for controlled surgical procedures. Fenestrated Gasper, Monopolar Hook, and Needle Holder complement the HandX system, targeting specific surgical applications. These products are sold directly to hospitals and surgical centers worldwide, with no mention of additional services or licensing agreements in the business description. Human Xtensions Ltd. serves the global medical device market, specifically focusing on minimally invasive surgical tools. The firm's products are designed to improve surgeon ergonomics and patient outcomes during laparoscopic procedures. Its subsidiary Human Xtensions Inc. supports international sales and distribution, ensuring global reach without specifying regional market segments or customer types beyond healthcare institutions. Human Xtensions is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Human Xtensions stock

Forward P/E Ratio of Human Xtensions is -0.25 in 2024.

Forward P/E Ratio of Human Xtensions changed from -0.16 to -0.25, representing a 59.48% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Forward P/E Ratio Human Xtensions since 2006 – with annual values, charts, and detailed analysis.

The Forward P/E uses estimated future earnings to value a stock. A lower forward P/E relative to the trailing P/E suggests analysts expect earnings growth.

To evaluate Forward P/E Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Forward P/E Ratio.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Forward P/E Ratio's Human Xtensions with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Valuation — Human Xtensions

P/EP/SEV/EBITP/BP/CFP/FCFPEGEV/RevenueEV/EBITDAEV/FCFEarnings YieldFCF YieldMarket capitalizationEnterprise ValueForward P/EP/TBVShareholder YieldBuyback YieldDiv.-Adj. PEGEV/OCF

All Key Metrics — Human Xtensions